Perceptive Advisors - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 141 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.05 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Perceptive Advisors ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2017$25,000
-92.0%
6,970
-90.2%
0.00%
-95.5%
Q2 2016$312,000
-82.9%
71,124
-28.9%
0.02%
-85.6%
Q4 2014$1,825,000
-46.7%
100,000
+3.5%
0.15%
+8.5%
Q3 2013$3,422,000–96,600–0.14%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2016
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders